Analystreport

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.

Oncternal Therapeutics, Inc.  (ONCT) 
Last oncternal therapeutics, inc. earnings: 8/8 04:01 pm Check Earnings Report